Compound 1245
Identifiers
- Canonical SMILES:
CN1CCC(CCNC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3([C@H]2c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc32)CC1
- IUPAC name:
(2'R,3S,3'S,5'R)-6-chloro-3'-(3-chloro-2-fluorophenyl)-5'-(2,2-dimethylpropyl)-N-[2-(1-methylpiperidin-4-yl)ethyl]-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide
- InChi:
InChI=1S/C31H39Cl2FN4O2/c1-30(2,3)17-24-31(21-9-8-19(32)16-23(21)36-29(31)40)25(20-6-5-7-22(33)26(20)34)27(37-24)28(39)35-13-10-18-11-14-38(4)15-12-18/h5-9,16,18,24-25,27,37H,10-15,17H2,1-4H3,(H,35,39)(H,36,40)/t24-,25+,27-,31-/m1/s1
- InChiKey:
COBIADBVPGXSFP-RQJGXFNESA-N
External links
![]() 168317817 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 8.70 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 588.24 g/mol | |||
HBA | 6 | |||
HBD | 3 | |||
HBA + HBD | 9 | |||
AlogP | 5.52 | |||
TPSA | 73.47 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
19928922 | 3 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 7.49 | |
19928922 | 3 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 8.70 | |
19928922 | 3 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | SJSA-1 cells | pIC50 (half maximal inhibitory concentration, -log10) | 6.52 |
19928922 | 3 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | Saos-2 cells | pIC50 (half maximal inhibitory concentration, -log10) | 5.48 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.9394 | SAR-405838 | DB12541 | |
0.7321 | Milademetan | DB15257 | |
0.5790 | Idasanutlin | DB12325 | |
0.5531 | Mosapramine | DB13676 | |
0.5280 | (3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE | DB07090 | |
0.5280 | (3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE | DB07222 | |
0.5191 | OPC-51803 | DB05838 | |
0.5185 | Degarelix | DB06699 | |
0.5185 | SLV-334 | DB15356 | |
0.5054 | OPC-14523 | DB05422 | |
0.5026 | Daglutril | DB05796 | |
0.4970 | 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone | DB02058 | |
0.4950 | Acyline | DB11906 | |
0.4946 | Lumateperone | DB06077 | |
0.4906 | Lorcainide | DB13653 |